Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
EARLY_PHASE1
15 participants
INTERVENTIONAL
2025-05-31
2025-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
HIT-Stroke Trial 2
NCT06268041
High Intensity Interval Training in Chronic Stroke Patients
NCT01777113
Powering Up Stroke Rehabilitation Through HIIT
NCT06554665
Effectiveness of High-intensity Aerobic Interval Training on Impairments and Activity Limitations in the Acute Phase of Stroke in Benin
NCT06179173
High-Intensity Interval Training in the Early Subacute Stroke With a Semi-recumbent Bike
NCT05804006
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low-Volume High Intensity Interval Training
This is the only arm in the study as it is a feasibility trial.
Low Volume High Intensity Interval Training
Participants will conduct aerobic exercise on a total body recumbent stepper to get their heart rates to levels consistent with high intensity exercise.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Low Volume High Intensity Interval Training
Participants will conduct aerobic exercise on a total body recumbent stepper to get their heart rates to levels consistent with high intensity exercise.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Ischemic or hemorrhagic stroke at consent. People with stroke and newly diagnosed cardiovascular complications had \>50% prevalence of recurrent stroke at 5 years. Index stroke or recurrent stroke on same side as index stroke will be allowed.
* Exercise continuously for minimum of 30 watts for 3 minutes on the recumbent stepper to demonstrate ability to perform the exercise test or therapist confirmation/documentation of participant's ability to use the recumbent stepper.
* No aerobic exercise contraindications or other safety/physical concerns during the submaximal exercise test determined by the therapy team or inpatient physicians.
* Able to communicate with investigators, follow 2-step command \& correctly answer consent comprehension questions
Exclusion Criteria
* Reported pain that limits or interferes with activities of daily living and physical activity/exercise
* Acute Myocardial Infarction in the last 2 days
* Ongoing unstable Angina
* Active Endocarditis
* Symptomatic Severe Aortic Stenosis
* Decompensated Heart Failure
* Acute Pulmonary Embolism, Pulmonary Insufficiency, or Deep Veinous Thrombosis
* Acute Myocarditis or Pericarditis
* Other significant neurologic, orthopedic, or peripheral vascular conditions that would limit exercise participation
* Oxygen-dependent chronic obstructive pulmonary disease
* Neurological disease (Multiple Sclerosis, Alzheimer's disease, Parkinson's disease)
* Pregnancy
18 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Kansas Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alexandra Arickx, MD
Role: PRINCIPAL_INVESTIGATOR
University of Kansas
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Informed Consent Form
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY00160192
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.